While our results suggest that SS, per se, is not associated with an increased frequency of STAT3 mutations in T-LGL leukemia, further studies are needed to more thoroughly assess the role of the STAT pathway in the development of concomitant SS and T-LGL leukemia. The gene discussed is SOAT1; the disease is synovial sarcoma.